sotalol has been researched along with Autoimmune Diseases in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleophas, TJ | 1 |
| van Lier, HJ | 1 |
| Faaber, P | 1 |
| Fennis, JF | 1 |
| van't Laar, A | 1 |
1 trial available for sotalol and Autoimmune Diseases
| Article | Year |
|---|---|
Therapeutic efficacy of alpha-adrenoceptor blockade in primary and secondary Raynaud's syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Autoimmune Diseases; Clinical Trials as Topic; Female; Hu | 1984 |